Month: October 2019

(Bloomberg) — Biogen Inc. will ask U.S. drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of data from two failed clinical trials showed promising results.The move by Biogen — if successful — would be the drug industry’s most dramatic reversal of fortune in history. The company said it made the decision after talking with the U.S. Food and Drug Administration and reviewing data showing the therapy helped Alzheimer’s patients’ cognitive function and their ability to perform basic tasks.In March, the company said a major trial of the drug, aducanumab, had …read more […]

Microsoft is set to report earnings tomorrow, and analysts have high expectations. Yahoo Finance’s Alexis Christoforous and Brian Sozzi preview the quarter with Dan Morgan, VP and Senior Portfolio Manager at Synovus Trust. …read more […]

The market has been volatile in the last few months as the Federal Reserve continued its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage […] …read more […]

Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the first […] …read more […]

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 20% in 2019 (through September 30th). Conversely, hedge […] …read more […]

Reuters reported on Monday that SoftBank had offered a package worth nearly $10 billion to WeWork and its shareholders under a plan that would keep the company afloat and lead to the exit of its Chairman Adam Neumann. The Wall Street Journal reported on Tuesday that under the deal agreed with the board, Neumann would be paid nearly $1.7 billion by SoftBank, funded by a new credit line and the sale of roughly $1 billion of his WeWork stock. …read more […]

(Bloomberg) — An auction next month of oilfields in Brazil may be the priciest ever held, raising at least $50 billion in licensing fees and compensation, according to people familiar with government estimates.Exxon Mobil Corp., Royal Dutch Shell Plc and other energy giants are set to vie for deep-sea deposits that could hold 15 billion barrels of oil, almost twice as much as Norway’s reserves. Winners at the Nov. 6 auction are expected to pay $25 billion in licensing fees, plus share a portion of their production with the government.In addition, bidders will need to negotiate payments to state-controlled Petroleo …read more […]

Mcdonalds reported a miss on profit and sales in its third quarter earnings, and investors are disappointed. Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung break down the numbers. …read more […]